Aura Biosciences’ (AURA) Buy Rating Reaffirmed at HC Wainwright
Aura Biosciences (NASDAQ:AURA – Get Free Report)‘s stock had its “buy” rating reiterated by analysts at HC Wainwright in a research report issued on Monday,Benzinga reports. They currently have a $22.00 price objective on the stock. HC Wainwright’s price target indicates a potential upside of 210.73% from the stock’s current price. Separately, Lifesci Capital upgraded […]
